Amneal Pharmaceuticals, Inc

(NYSE:AMRX)

Latest On Amneal Pharmaceuticals, Inc (AMRX):

Date/Time Type Description Signal Details
2023-05-05 23:59 ESTNewsAmneal Pharmaceuticals, Inc. 2023 Q1 - Results - Earnings Call PresentationN/A
2023-05-05 23:59 ESTNewsAmneal Pharmaceuticals, Inc. (AMRX) Q1 2023 Earnings Call TranscriptN/A
2023-05-05 11:00 ESTNewsAmneal Pharmaceuticals Non-GAAP EPS of $0.12 beats by $0.02, revenue of $558M beats by $15.82MN/A
2023-05-04 22:14 ESTNewsAmneal Pharmaceuticals Q1 2023 Earnings PreviewN/A
2023-04-17 18:46 ESTNewsAmneal pops 3% after early look at Q1 results, re-affirms FY23 guidanceN/A
2023-03-10 04:46 ESTNewsGene therapy developer AskBio appoints ex Amneal commercial chief as CEON/A
2023-03-02 13:04 ESTNewsAmneal Pharmaceuticals Non-GAAP EPS of $0.23 beats by $0.02, revenue of $610M beats by $30.07MN/A
2023-03-02 13:04 ESTNewsAmneal stock rises ~15% on FDA review of Narcan generic, Q4 beatN/A
2023-03-02 13:03 ESTNewsAmneal Pharmaceuticals, Inc. (AMRX) Q4 2022 Earnings Call TranscriptN/A
2023-03-01 22:47 ESTNewsAmneal Pharmaceuticals Q4 2022 Earnings PreviewN/A
2023-01-25 13:44 ESTNewsIntercept Pharma gains after patent settlement with AmnealN/A
2023-01-24 00:26 ESTNewsAmneal Pharmaceuticals: Risk Still PersistsN/A
2023-01-15 19:42 ESTNewsDrugmakers welcome new year with 450 drug price hikes so farN/A
2023-01-11 19:58 ESTNewsAmneal Pharmaceuticals (AMRX) presents at 41st Annual J.P. Morgan Healthcare Conference - SlideshowN/A
2023-01-10 19:47 ESTNewsAmneal Pharma reaffirms 2022 guidanceN/A
2023-01-04 16:19 ESTNewsAmneal joins hands with Orion to commercialize generic products in Europe and more countriesN/A
2022-12-15 05:51 ESTNewsAmneal Pharmaceuticals large shareholder TPG cuts stakeN/A
2022-11-12 00:59 ESTNewsFDA accepts Amneal Pharmaceuticals NDA for Parkinson's drug IPX203N/A
2022-11-04 15:45 ESTNewsAmneal Pharmaceuticals Non-GAAP EPS of $0.14 misses by $0.04, revenue of $545.56M misses by $16.61MN/A
2022-11-04 15:45 ESTNewsAmneal Pharmaceuticals, Inc. 2022 Q3 - Results - Earnings Call PresentationN/A
2022-11-04 15:44 ESTNewsAmneal Pharmaceuticals, Inc. (AMRX) Q3 2022 Earnings Call TranscriptN/A
2022-11-03 23:09 ESTNewsAmneal Pharmaceuticals Q3 2022 Earnings PreviewN/A
2022-11-02 13:25 ESTNewsAMD, JD and BILI are among pre market gainersN/A
2022-11-02 13:25 ESTNewsAmneal Pharma gets FDA nod for leuprolide acetate injection to treat prostate cancerN/A
2022-10-28 12:24 ESTNewsAmneal Pharmaceuticals: A Small 'Thumbs Up'N/A
2022-09-01 01:51 ESTNewsAmneal Pharma submits NDA for novel formulation of Parkinson's disease treatmentN/A
2022-08-06 06:05 ESTNewsAmneal Pharmaceuticals, Inc. (AMRX) Management Team on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-05 14:38 ESTNewsAmneal Pharmaceuticals Non-GAAP EPS of $0.19 in-line, revenue of $559M beats by $24.56M, revises FY earning guidanceN/A
2022-08-05 14:37 ESTNewsAmneal shares lower after generic drugmaker cuts FY 2022 profit outlookN/A
2022-08-04 23:18 ESTNewsAmneal Pharmaceuticals Q2 2022 Earnings PreviewN/A
2022-06-01 11:05 ESTNewsAmneal launches Lyvispah for muscle tightness due to spinal cord & neurological disordersN/A
2022-05-27 16:22 ESTNewsAmneal, Kashiv's biosimilar therapy to Amgen's Neulasta gets FDA approvalN/A
2022-05-04 22:47 ESTNewsAmneal Pharmaceuticals Non-GAAP EPS of $0.12 misses by $0.01, revenue of $497.63M misses by $4.66MN/A
2022-05-04 22:44 ESTNewsAmneal falls 12% on disappointing Q1 resultN/A
2022-05-04 22:43 ESTNewsAmneal Pharmaceuticals, Inc. (AMRX) Management Team on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-04 22:43 ESTNewsAmneal Pharmaceuticals, Inc. 2022 Q1 - Results - Earnings Call PresentationN/A
2022-05-04 03:16 ESTNewsAmneal Pharmaceuticals Q1 2022 Earnings PreviewN/A
2022-04-14 04:45 ESTNewsAmneal Pharmaceuticals gets second U.S. biosimilar approval with FDA nod for AlymsysN/A
2022-03-31 06:49 ESTNewsAmneal Pharmaceuticals: Generics And Biosimilars Play Has Strong Upside Potential Under New / Old ManagementN/A
2022-03-02 13:22 ESTNewsAmneal Pharmaceuticals Non-GAAP EPS of $0.18 misses by $0.02, revenue of $537M beats by $3.59MN/A
2022-03-02 13:21 ESTNewsAmneal Pharmaceuticals, Inc. 2021 Q4 - Results - Earnings Call PresentationN/A
2022-03-02 13:21 ESTNewsAmneal stock falls 8% following Q4 results; FY22 EPS outlook seen below estimatesN/A
2022-03-02 13:21 ESTNewsAmneal Pharmaceuticals (AMRX) CEO, Chirag Patel on Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-01 21:00 ESTNewsAmneal Pharmaceuticals Q4 2021 Earnings PreviewN/A
2022-02-17 10:31 ESTNewsAmneal gets FDA nod for 4 generic injectables productsN/A
2022-01-05 17:08 ESTNewsAmneal acquires Saol Therapeutics’ Baclofen franchise for $83.5MN/A
2021-12-22 12:19 ESTNewsRevisiting Amneal Pharmaceuticals After Its CEO Buys SharesN/A
2021-11-20 04:05 ESTNewsAmneal receives ANDA approval for difluprednate ophthalmic emulsionN/A
2021-11-04 03:51 ESTNewsAmneal Pharmaceuticals, Inc. 2021 Q3 - Results - Earnings Call PresentationN/A
2021-11-04 03:51 ESTNewsAmneal Pharmaceuticals, Inc. (AMRX) CEO Chintu Patel on Q3 2021 Results - Earnings Call TranscriptN/A

About Amneal Pharmaceuticals, Inc (AMRX):

Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates in three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals across a range of therapeutic categories. The Specialty segment is involved in the development, promotion, distribution, and sale of branded pharmaceutical products primarily for central nervous system disorders, endocrinology, parasitic infections, and other therapeutic areas. It also offers licensed, owned, niche, and mature branded products, as well as Rytary for the treatment of Parkinson's disease; Zomig for the treatment of migraine headaches; Emverm a chewable tablets for the treatment of pinworm, whipworm, common roundworm, common hookworm, and American hookworm in single or mixed infections; and Unithroid for the treatment of hypothyroidism. The AvKARE segment provides pharmaceuticals, medical and surgical products, and services primarily to governmental agencies, the Department of Defense, and the Department of Veterans Affairs. It is also involved in the wholesale distribution of bottle and unit dose pharmaceuticals under the AvKARE and AvPAK names, as well as medical and surgical products; and packaging and wholesale distribution of pharmaceuticals and vitamins to its retail and institutional customers. The company sells its products through wholesalers, distributors, hospitals, chain pharmacies, and individual pharmacies. It operates in the United States, India, Ireland, and internationally. The company was formerly known as Atlas Holdings, Inc. and changed its name to Amneal Pharmaceuticals, Inc. in 2018. Amneal Pharmaceuticals, Inc. was founded in 2002 and is based in Bridgewater, New Jersey.

See Advanced Chart

General

  • Name Amneal Pharmaceuticals, Inc
  • Symbol AMRX
  • Type Common Stock
  • Exchange NYSE
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryDrug Manufacturers-Specialty & Generic
  • Full Time Employees 6,000
  • Fiscal Year EndDecember
  • IPO Date2009-01-15
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryPharmaceuticals
  • Gic SubIndustryPharmaceuticals
  • Web URLhttp://www.amneal.com
View More

Valuation

  • Trailing PE 11.33
  • Forward PE 8.36
  • Price/Sales (Trailing 12 Mt.) 0.45
  • Price/Book (Most Recent Quarter) 2.93
  • Enterprise Value Revenue 1.75
  • Enterprise Value EBITDA 10.1
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate $0.78
  • Next Year EPS Estimate $0.87
  • Next Quarter EPS Estimate $0.16
  • Profit Margin 5%
  • Operating Margin 7%
  • Return on Assets 2%
  • Return on Equity 20%
  • Revenue 1.99 billion
  • Earnings Per Share $0.61
  • Revenue Per Share $13.51
  • Gross Profit 652.32 million
  • Quarterly Earnings Growth 28.4%
View More

Highlights

  • Market Capitalization 1.02 billion
  • EBITDA 381.05 million
  • PE Ratio -13.59
  • Analyst Target Price $6.1
  • Book Value Per Share $2.05
View More

Share Statistics

  • Shares Outstanding 147.7 million
  • Shares Float 94.49 million
  • % Held by Insiders 1043%
  • % Held by Institutions 69.86%
  • Shares Short 5.45 million
  • Shares Short Prior Month 4.99 million
  • Short Ratio 3.45
  • Short % of Float 7%
  • Short % of Shares Outstanding 4%
View More

Technicals

  • Beta 1.29
  • 52 Week High $7.32
  • 52 Week Low $2.71
  • 50 Day Moving Average 5.49
  • 200 Day Moving Average 4.67
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Amneal Pharmaceuticals, Inc (AMRX) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Amneal Pharmaceuticals, Inc (AMRX) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-26$N/A$0.14$0.135.42%
2020-09-302020-11-06$N/A$0.16$0.1231.58%
2020-06-302020-08-06$N/A$0.13$0.1034.85%
2020-03-312020-05-11$498.53 million$0.20$0.09123.21%
2019-12-312020-02-26$397.33 million$0.08$0.0556.56%
2019-09-302019-11-06$378.28 million$0.04$0.13-68.6%
2019-06-302019-08-05$404.64 million$0.09$0.12-27.18%
2019-03-312019-05-09$446.12 million$0.14$0.18-20.95%
2018-12-312019-02-28$497.53 million$0.33$0.2721.01%
2018-09-302018-11-07$476.49 million$0.28$0.272.23%
2018-06-302018-08-09$413.79 million$0.24$0.227.33%
2018-03-312018-05-11$275.19 million$0.14$0.17-17.65%
2017-12-312018-03-01$1.03 billion$0.11$0.110%
2017-09-302017-11-09$-107085000$0.23$0.2015%
2017-06-302017-08-09$478.56 million$0.18$0.1428.57%
2017-03-312017-05-10$-371471000$0.11$0.13-15.38%
2016-12-312017-03-01$298.58 million$0.16$0.160%
2016-09-302016-11-09$0.37$0.39-5.13%
2016-06-302016-08-09$0.21$0.32-34.38%
2016-03-312016-05-10$0.43$0.3910.26%
2015-12-312016-02-22$0.62$0.4440.91%
2015-09-302015-11-09$0.40$0.392.56%
2015-06-302015-08-10$0.34$0.35-2.86%
2015-03-312015-05-11$0.09$0.18-50%
2014-12-312015-02-24$0.16$0.1233.33%
2014-09-302014-11-04$0.33$0.316.45%
2014-06-302014-08-06$0.60$0.3666.67%
2014-03-312014-05-01$0.24$0.05380%
2013-12-312014-02-20-$0.02$0.03-166.67%
2013-09-302013-11-04$0.25-$0.07457.14%
2013-06-302013-08-08$0.23$0.04475%
2013-03-312013-05-01$0.37$0.2085%
2012-12-312013-02-25$0.30$0.1957.89%
2012-09-302012-10-30$0.48$0.50-4%
2012-06-302012-07-31$0.60$0.4533.33%
2012-03-312012-05-01$0.55$0.4912.24%
2011-12-312012-02-28$0.36$0.2263.64%
2011-09-302011-11-01$0.30$0.2330.43%
2011-06-302011-08-02$0.22$0.1915.79%
2011-03-312011-05-03$0.24$0.1560%
2010-12-312011-02-24$0.23$0.224.55%
2010-09-302010-11-02$0.24$0.26-7.69%
2010-06-302010-08-03$0.48$0.51-5.88%
2010-03-312010-05-04$2.06$0.51303.92%
2009-12-312010-02-25$0.69$0.14392.86%
2009-09-302009-11-03$0.11$0.05120%
2009-06-302009-08-04$0.05$0.0366.67%
2004-09-302004-11-09$0.01$0.05-80%
2004-06-302004-08-04$0.01$0.03-66.67%
2004-03-312004-05-05$0.14-$0.03566.67%
2003-12-312004-02-17-$0.05-$0.050%
2003-09-302003-11-05-$0.07-$0.02-250%
2003-06-302003-07-28-$0.05-$0.0616.67%
2003-03-312003-04-30-$0.07-$0.0812.5%
2002-12-312003-02-12-$0.07-$0.1136.36%
2002-09-302002-10-28-$0.11-$0.1315.38%
2002-06-302002-07-25-$0.13-$0.12-8.33%
2002-03-312002-04-30-$0.12-$0.137.69%
2001-12-312002-02-07-$0.15-$0.14-7.14%
2001-09-302001-10-30-$0.15-$0.14-7.14%
2001-06-302001-07-31-$0.15-$0.1816.67%
2001-03-312001-05-02-$0.16-$0.2123.81%
2000-12-312001-02-08-$0.20-$0.2313.04%
2000-09-302000-10-31-$0.18-$0.2114.29%
2000-06-302000-07-31-$0.21-$0.18-16.67%

Amneal Pharmaceuticals, Inc (AMRX) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Amneal Pharmaceuticals, Inc (AMRX) Chart:

Amneal Pharmaceuticals, Inc (AMRX) News:

Below you will find a list of latest news for Amneal Pharmaceuticals, Inc (AMRX) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Amneal Pharmaceuticals, Inc (AMRX) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2024-08-162.50CALL0 0745.93TRUE00
2024-08-1651.67CALL0 1252.67TRUE00
2024-08-167.50.75CALL0 485103.77FALSE00
2024-08-16100.1CALL0 993.13FALSE00
2024-08-1612.50.05CALL0 10FALSE00
2024-08-162.50PUT0 00FALSE00
2024-08-1650.15PUT0 60FALSE00
2024-08-167.50.85PUT0 590TRUE00
2024-08-16100PUT0 0170.68TRUE00
2024-08-1612.50PUT0 0121.02TRUE00
2024-09-202.54.07CALL0 27364.95TRUE00
2024-09-2052.35CALL0 89143.26TRUE00
2024-09-207.50.75CALL0 32057.45FALSE00
2024-09-20100.22CALL0 320FALSE00
2024-09-2012.50.55CALL0 30FALSE00
2024-09-202.50.21PUT0 40FALSE00
2024-09-2050.35PUT0 4880FALSE00
2024-09-207.51.9PUT0 210TRUE00
2024-09-20103.6PUT0 1139.81TRUE00
2024-09-2012.50PUT0 0178.87TRUE00
2024-12-202.54.75CALL0 27108.48TRUE00
2024-12-2052.72CALL0 3668.49TRUE00
2024-12-207.51.2CALL0 30283.48FALSE00
2024-12-20100.6CALL0 3668.89FALSE00
2024-12-2012.50.29CALL0 20FALSE00
2024-12-202.50PUT0 00FALSE00
2024-12-2050.4PUT0 664.44FALSE00
2024-12-207.51PUT0 160TRUE00
2024-12-20100PUT0 0108.77TRUE00
2024-12-2012.50PUT0 090TRUE00
2025-03-212.50CALL0 0530.43TRUE00
2025-03-2150CALL0 064.23TRUE00
2025-03-217.50CALL0 00FALSE00
2025-03-21100CALL0 00FALSE00
2025-03-2112.50CALL0 00FALSE00
2025-03-21150CALL0 00FALSE00
2025-03-212.50PUT0 00FALSE00
2025-03-2150PUT0 00FALSE00
2025-03-217.50PUT0 00TRUE00
2025-03-21100PUT0 063.8TRUE00
2025-03-2112.50PUT0 069.25TRUE00
2025-03-21150PUT0 064.58TRUE00

Latest AMRX Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST100$3.03
Jun 13, 2022 7:59 PM EST100$3.03
Jun 13, 2022 7:59 PM EST415$3.03
Jun 13, 2022 7:59 PM EST200$3.03
Jun 13, 2022 7:59 PM EST100$3.03

Amneal Pharmaceuticals, Inc (AMRX) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-05-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000120919120030339/0001209191-20-030339-index.htm
2018-11-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1723128/000008025518002959/0000080255-18-002959-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1723128/000008025519002754/0000080255-19-002754-index.htm
2019-09-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1723128/000008025519002934/0000080255-19-002934-index.htm
2019-12-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1723128/000008025519003018/0000080255-19-003018-index.htm
2019-02-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1723128/000021545719006845/0000215457-19-006845-index.htm
2019-02-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1723128/000031506619000863/0000315066-19-000863-index.htm
2020-02-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1723128/000031506620000784/0000315066-20-000784-index.htm
2020-02-05SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1723128/000083423720004817/0000834237-20-004817-index.htm
2019-08-26SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1723128/000089843219001108/0000898432-19-001108-index.htm
2019-08-26SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1723128/000089843219001109/0000898432-19-001109-index.htm
2019-09-11SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1723128/000089843219001162/0000898432-19-001162-index.htm
2020-03-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000089924320006625/0000899243-20-006625-index.htm
2020-03-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000089924320006627/0000899243-20-006627-index.htm
2020-03-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000089924320006629/0000899243-20-006629-index.htm
2020-03-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000089924320006633/0000899243-20-006633-index.htm
2020-03-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000089924320006635/0000899243-20-006635-index.htm
2020-03-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000089924320006636/0000899243-20-006636-index.htm
2020-03-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000089924320006637/0000899243-20-006637-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000089924320006807/0000899243-20-006807-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000089924320006808/0000899243-20-006808-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000089924320006809/0000899243-20-006809-index.htm
2020-03-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000089924320007819/0000899243-20-007819-index.htm
2020-03-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000089924320007820/0000899243-20-007820-index.htm
2020-03-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000089924320007821/0000899243-20-007821-index.htm
2020-03-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000089924320007988/0000899243-20-007988-index.htm
2020-03-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000089924320007990/0000899243-20-007990-index.htm
2020-03-163Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000089924320008424/0000899243-20-008424-index.htm
2020-03-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000089924320008429/0000899243-20-008429-index.htm
2020-03-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000089924320009026/0000899243-20-009026-index.htm
2020-05-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000089924320012068/0000899243-20-012068-index.htm
2020-05-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000089924320012183/0000899243-20-012183-index.htm
2020-05-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000089924320012185/0000899243-20-012185-index.htm
2020-05-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000089924320012186/0000899243-20-012186-index.htm
2020-05-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000089924320012187/0000899243-20-012187-index.htm
2020-05-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000089924320012257/0000899243-20-012257-index.htm
2020-05-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000089924320012259/0000899243-20-012259-index.htm
2020-05-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000089924320012261/0000899243-20-012261-index.htm
2020-05-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000089924320012265/0000899243-20-012265-index.htm
2020-05-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000089924320012444/0000899243-20-012444-index.htm
2020-05-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000089924320012451/0000899243-20-012451-index.htm
2020-05-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000089924320012452/0000899243-20-012452-index.htm
2020-05-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000089924320012453/0000899243-20-012453-index.htm
2020-05-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000089924320012466/0000899243-20-012466-index.htm
2018-11-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1723128/000090221918000529/0000902219-18-000529-index.htm
2019-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1723128/000090221919000126/0000902219-19-000126-index.htm
2020-01-28SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1723128/000090221920000328/0000902219-20-000328-index.htm
2019-08-07SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1723128/000091412119002136/0000914121-19-002136-index.htm
2019-08-07SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1723128/000091412119002138/0000914121-19-002138-index.htm
2019-01-31SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1723128/000093247119002240/0000932471-19-002240-index.htm
2019-02-11SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1723128/000093247119004732/0000932471-19-004732-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1723128/000110465920017627/0001104659-20-017627-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1723128/000110465920018499/0001104659-20-018499-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1723128/000110465920020703/0001104659-20-020703-index.htm
2019-08-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000114420419038060/0001144204-19-038060-index.htm
2019-08-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000114420419038365/0001144204-19-038365-index.htm
2018-11-13424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1723128/000119312518325599/0001193125-18-325599-index.htm
2019-03-018-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1723128/000119312519059421/0001193125-19-059421-index.htm
2019-03-01POSASRPost-effective Amendment to an automatic shelf registration statementhttps://www.sec.gov/Archives/edgar/data/1723128/000119312519059683/0001193125-19-059683-index.htm
2019-03-01S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuershttps://www.sec.gov/Archives/edgar/data/1723128/000119312519061022/0001193125-19-061022-index.htm
2019-10-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1723128/000119312519266540/0001193125-19-266540-index.htm
2019-10-11PRE 14COther preliminary information statementshttps://www.sec.gov/Archives/edgar/data/1723128/000119312519266797/0001193125-19-266797-index.htm
2019-10-21DEF 14COther definitive information statementshttps://www.sec.gov/Archives/edgar/data/1723128/000119312519270854/0001193125-19-270854-index.htm
2019-12-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1723128/000119312519310283/0001193125-19-310283-index.htm
2019-12-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1723128/000119312519315267/0001193125-19-315267-index.htm
2020-01-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1723128/000119312520007787/0001193125-20-007787-index.htm
2020-02-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1723128/000119312520023178/0001193125-20-023178-index.htm
2020-02-208-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1723128/000119312520043609/0001193125-20-043609-index.htm
2020-02-208-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1723128/000119312520043613/0001193125-20-043613-index.htm
2020-02-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1723128/000119312520050188/0001193125-20-050188-index.htm
2020-03-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1723128/000119312520071730/0001193125-20-071730-index.htm
2020-04-15DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1723128/000119312520108170/0001193125-20-108170-index.htm
2020-04-178-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1723128/000119312520110622/0001193125-20-110622-index.htm
2020-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1723128/000119312520136972/0001193125-20-136972-index.htm
2020-08-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1723128/000119312520209316/0001193125-20-209316-index.htm
2020-08-17S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1723128/000119312520222437/0001193125-20-222437-index.htm
2020-01-093Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000120919120002856/0001209191-20-002856-index.htm
2020-01-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000120919120004719/0001209191-20-004719-index.htm
2020-02-145Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000120919120009662/0001209191-20-009662-index.htm
2020-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000120919120029727/0001209191-20-029727-index.htm
2020-05-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000120919120030339/0001209191-20-030339-index.htm
2020-08-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000120919120044578/0001209191-20-044578-index.htm
2020-08-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000120919120044579/0001209191-20-044579-index.htm
2020-08-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000120919120044581/0001209191-20-044581-index.htm
2019-03-22DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1723128/000130817919000058/0001308179-19-000058-index.htm
2019-03-22DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1723128/000130817919000059/0001308179-19-000059-index.htm
2020-03-23DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1723128/000130817920000070/0001308179-20-000070-index.htm
2020-03-23DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1723128/000130817920000071/0001308179-20-000071-index.htm
2019-07-193Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000138713119005208/0001387131-19-005208-index.htm
2019-07-19SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1723128/000138713119005210/0001387131-19-005210-index.htm
2019-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1723128/000156459019040651/0001564590-19-040651-index.htm
2019-11-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1723128/000156459019041240/0001564590-19-041240-index.htm
2020-02-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1723128/000156459020006564/0001564590-20-006564-index.htm
2020-03-0210-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1723128/000156459020008179/0001564590-20-008179-index.htm
2020-05-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1723128/000156459020023833/0001564590-20-023833-index.htm
2020-05-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1723128/000156459020024256/0001564590-20-024256-index.htm
2019-11-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000162828019013997/0001628280-19-013997-index.htm
2018-12-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1723128/000172312818000039/0001723128-18-000039-index.htm
2019-01-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000005/0001723128-19-000005-index.htm
2019-01-073Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000007/0001723128-19-000007-index.htm
2019-01-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000009/0001723128-19-000009-index.htm
2019-01-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000011/0001723128-19-000011-index.htm
2019-01-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000013/0001723128-19-000013-index.htm
2019-01-233Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000015/0001723128-19-000015-index.htm
2019-01-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000017/0001723128-19-000017-index.htm
2019-01-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000019/0001723128-19-000019-index.htm
2019-02-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000023/0001723128-19-000023-index.htm
2019-03-0110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1723128/000172312819000028/0001723128-19-000028-index.htm
2019-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000033/0001723128-19-000033-index.htm
2019-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000034/0001723128-19-000034-index.htm
2019-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000035/0001723128-19-000035-index.htm
2019-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000036/0001723128-19-000036-index.htm
2019-03-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000038/0001723128-19-000038-index.htm
2019-03-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000040/0001723128-19-000040-index.htm
2019-03-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000042/0001723128-19-000042-index.htm
2019-05-073Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000049/0001723128-19-000049-index.htm
2019-05-073Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000050/0001723128-19-000050-index.htm
2019-05-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000064/0001723128-19-000064-index.htm
2019-05-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000065/0001723128-19-000065-index.htm
2019-05-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000066/0001723128-19-000066-index.htm
2019-05-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000067/0001723128-19-000067-index.htm
2019-05-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000068/0001723128-19-000068-index.htm
2019-05-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000069/0001723128-19-000069-index.htm
2019-05-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000070/0001723128-19-000070-index.htm
2019-05-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000071/0001723128-19-000071-index.htm
2019-05-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000072/0001723128-19-000072-index.htm
2019-05-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000073/0001723128-19-000073-index.htm
2019-05-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000074/0001723128-19-000074-index.htm
2019-05-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000076/0001723128-19-000076-index.htm
2019-05-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1723128/000172312819000079/0001723128-19-000079-index.htm
2019-05-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000081/0001723128-19-000081-index.htm
2019-05-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000087/0001723128-19-000087-index.htm
2019-05-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000088/0001723128-19-000088-index.htm
2019-05-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000089/0001723128-19-000089-index.htm
2019-05-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000090/0001723128-19-000090-index.htm
2019-05-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000091/0001723128-19-000091-index.htm
2019-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000094/0001723128-19-000094-index.htm
2019-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000095/0001723128-19-000095-index.htm
2019-05-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000097/0001723128-19-000097-index.htm
2019-07-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000100/0001723128-19-000100-index.htm
2019-08-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000105/0001723128-19-000105-index.htm
2019-08-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000107/0001723128-19-000107-index.htm
2019-08-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1723128/000172312819000111/0001723128-19-000111-index.htm
2019-08-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000112/0001723128-19-000112-index.htm
2019-08-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000114/0001723128-19-000114-index.htm
2019-08-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000116/0001723128-19-000116-index.htm
2019-08-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000118/0001723128-19-000118-index.htm
2019-08-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000120/0001723128-19-000120-index.htm
2019-11-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000127/0001723128-19-000127-index.htm
2019-11-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000128/0001723128-19-000128-index.htm
2019-11-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000129/0001723128-19-000129-index.htm
2019-11-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000130/0001723128-19-000130-index.htm
2019-11-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000131/0001723128-19-000131-index.htm
2019-12-163Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000138/0001723128-19-000138-index.htm
2019-12-163Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000139/0001723128-19-000139-index.htm
2019-12-163Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000140/0001723128-19-000140-index.htm
2019-12-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000144/0001723128-19-000144-index.htm
2019-12-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000145/0001723128-19-000145-index.htm
2019-12-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000146/0001723128-19-000146-index.htm
2020-01-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312820000002/0001723128-20-000002-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1723128/000172312820000010/0001723128-20-000010-index.htm
2020-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1723128/000172312820000013/0001723128-20-000013-index.htm
2020-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1723128/000172312820000023/0001723128-20-000023-index.htm
2020-11-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1723128/000172312820000026/0001723128-20-000026-index.htm

Amneal Pharmaceuticals, Inc (AMRX) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Amneal Pharmaceuticals, Inc (AMRX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 1043%
Institutional Ownership: 6986%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-05-19John KielyDirectorBuy10,000.004.4044,000.0010,000.00https://www.sec.gov/Archives/edgar/data/1723128/000120919120030339/0001209191-20-030339-index.htm
2019-05-07Robert A StewartPresident and CEOBuy83,277.00100,277.00https://www.sec.gov/Archives/edgar/data/1723128/000172312819000088/0001723128-19-000088-index.htm
2020-03-01ANDREW S BOYERExec VP, Comm OptnsBuy12,345.00108,313.00https://www.sec.gov/Archives/edgar/data/1723128/000089924320006808/0000899243-20-006808-index.htm
2020-05-07ANDREW S BOYERExec VP, Comm OptnsBuy16,656.00118,286.00https://www.sec.gov/Archives/edgar/data/1723128/000089924320012466/0000899243-20-012466-index.htm
2020-05-07Emily Peterson AlvaDirectorBuy6,459.0012,566.00https://www.sec.gov/Archives/edgar/data/1723128/000089924320012265/0000899243-20-012265-index.htm
2020-03-17PAUL M MEISTERDirectorBuy149,439.002.79416,934.81149,439.00https://www.sec.gov/Archives/edgar/data/1723128/000089924320009026/0000899243-20-009026-index.htm
2020-03-03Gautam PatelDirectorBuy117,889.003.94464,482.66156,107.00https://www.sec.gov/Archives/edgar/data/1723128/000089924320007820/0000899243-20-007820-index.htm
2020-05-07Gautam PatelDirectorBuy6,459.00162,566.00https://www.sec.gov/Archives/edgar/data/1723128/000089924320012259/0000899243-20-012259-index.htm
2019-08-05International Ltd Fosun10% Share HolderBuy1,642,300.003.044,992,592.001,642,300.00https://www.sec.gov/Archives/edgar/data/1723128/000114420419038060/0001144204-19-038060-index.htm
2019-03-12PAUL BISAROExecutive ChairmanBuy17,000.0011.97203,490.0017,000.00https://www.sec.gov/Archives/edgar/data/1723128/000172312819000040/0001723128-19-000040-index.htm
2019-03-12Robert A StewartPresident and CEOBuy17,000.0011.92202,640.0017,000.00https://www.sec.gov/Archives/edgar/data/1723128/000172312819000042/0001723128-19-000042-index.htm
2019-05-07Nikita ShahSVP, Chief HR OfficerBuy4,441.00170,477.00https://www.sec.gov/Archives/edgar/data/1723128/000172312819000087/0001723128-19-000087-index.htm
2019-05-08J KEVIN BUCHIDirectorBuy6,107.0017,408.00https://www.sec.gov/Archives/edgar/data/1723128/000172312819000074/0001723128-19-000074-index.htm
2020-03-01Nikita ShahSVP, Chief HR OfficerBuy11,728.00180,839.00https://www.sec.gov/Archives/edgar/data/1723128/000089924320006809/0000899243-20-006809-index.htm
2020-05-07Nikita ShahSVP, Chief HR OfficerBuy4,442.00181,053.00https://www.sec.gov/Archives/edgar/data/1723128/000089924320012453/0000899243-20-012453-index.htm
2019-05-08Janet S. VergisDirectorBuy6,107.0018,257.00https://www.sec.gov/Archives/edgar/data/1723128/000172312819000068/0001723128-19-000068-index.htm
2019-05-07ANDREW S BOYERExec VP, Comm OptnsBuy16,655.0018,655.00https://www.sec.gov/Archives/edgar/data/1723128/000172312819000090/0001723128-19-000090-index.htm
2019-05-07Joseph TodiscoSVP, Specialty CommercialBuy4,441.00192,818.00https://www.sec.gov/Archives/edgar/data/1723128/000172312819000091/0001723128-19-000091-index.htm
2020-03-03Chirag K. PatelPresident, Co-CEO & DirectorBuy156,421.003.88606,913.48197,169.00https://www.sec.gov/Archives/edgar/data/1723128/000089924320007821/0000899243-20-007821-index.htm
2020-03-03Chintu PatelCo-CEO and DirectorBuy156,539.003.88607,371.32197,342.00https://www.sec.gov/Archives/edgar/data/1723128/000089924320007819/0000899243-20-007819-index.htm
2020-01-22Todd P. BranningSVP and CFOBuy20,096.0020,096.00https://www.sec.gov/Archives/edgar/data/1723128/000120919120004719/0001209191-20-004719-index.htm
2019-05-13Joseph TodiscoSVP, Specialty CommercialBuy15,000.009.88148,200.00205,590.00https://www.sec.gov/Archives/edgar/data/1723128/000172312819000094/0001723128-19-000094-index.htm
2020-05-15Jeffrey P. GeorgeDirectorBuy23,810.004.1699,049.6023,810.00https://www.sec.gov/Archives/edgar/data/1723128/000120919120029727/0001209191-20-029727-index.htm
2020-05-07J KEVIN BUCHIDirectorBuy6,459.0023,867.00https://www.sec.gov/Archives/edgar/data/1723128/000089924320012257/0000899243-20-012257-index.htm
2020-02-28Joseph TodiscoSVP, Specialty CommercialBuy40,000.003.62144,800.00246,845.00https://www.sec.gov/Archives/edgar/data/1723128/000089924320006807/0000899243-20-006807-index.htm
2019-03-06PETER R TERRERIDirectorSell23,345.0012.39289,244.5525,192.00https://www.sec.gov/Archives/edgar/data/1723128/000172312819000038/0001723128-19-000038-index.htm
2020-03-04Chintu PatelCo-CEO and DirectorBuy58,765.003.97233,297.05256,107.00https://www.sec.gov/Archives/edgar/data/1723128/000089924320007819/0000899243-20-007819-index.htm
2020-03-04Chirag K. PatelPresident, Co-CEO & DirectorBuy58,938.003.97233,983.86256,107.00https://www.sec.gov/Archives/edgar/data/1723128/000089924320007821/0000899243-20-007821-index.htm
2020-05-07Joseph TodiscoSVP, Specialty CommercialBuy4,442.00256,236.00https://www.sec.gov/Archives/edgar/data/1723128/000089924320012452/0000899243-20-012452-index.htm
2020-03-01Joseph TodiscoSVP, Specialty CommercialBuy11,111.00257,956.00https://www.sec.gov/Archives/edgar/data/1723128/000089924320006807/0000899243-20-006807-index.htm
2020-08-02PAUL M MEISTERDirectorBuy27,923.0027,923.00https://www.sec.gov/Archives/edgar/data/1723128/000120919120044581/0001209191-20-044581-index.htm
2020-01-03DAVID A BUCHENSVP, Chief Legal OfficerBuy27,614.0028,614.00https://www.sec.gov/Archives/edgar/data/1723128/000172312820000002/0001723128-20-000002-index.htm
2019-05-13ANDREW S BOYERExec VP, Comm OptnsBuy19,000.009.46179,740.0029,302.00https://www.sec.gov/Archives/edgar/data/1723128/000172312819000095/0001723128-19-000095-index.htm
2019-08-06International Ltd Fosun10% Share HolderBuy327,000.002.91951,570.00327,000.00https://www.sec.gov/Archives/edgar/data/1723128/000114420419038365/0001144204-19-038365-index.htm
2020-03-18PAUL M MEISTERDirectorBuy204,210.002.71553,409.10353,649.00https://www.sec.gov/Archives/edgar/data/1723128/000089924320009026/0000899243-20-009026-index.htm
2020-03-10Chintu PatelCo-CEO and DirectorBuy100,000.003.09309,000.00356,107.00https://www.sec.gov/Archives/edgar/data/1723128/000089924320007990/0000899243-20-007990-index.htm
2020-03-10Chirag K. PatelPresident, Co-CEO & DirectorBuy100,000.003.09309,000.00356,107.00https://www.sec.gov/Archives/edgar/data/1723128/000089924320007988/0000899243-20-007988-index.htm
2020-05-07Chintu PatelCo-CEO and DirectorBuy6,459.00362,566.00https://www.sec.gov/Archives/edgar/data/1723128/000089924320012444/0000899243-20-012444-index.htm
2020-05-07Chirag K. PatelPresident, Co-CEO & DirectorBuy6,459.00362,566.00https://www.sec.gov/Archives/edgar/data/1723128/000089924320012451/0000899243-20-012451-index.htm
2019-08-16Pradeep BhadauriaSVP, Chief Scientific OfficerBuy30,000.002.4172,300.0037,500.00https://www.sec.gov/Archives/edgar/data/1723128/000172312819000118/0001723128-19-000118-index.htm
2020-03-02Gautam PatelDirectorBuy32,111.003.88124,590.6838,218.00https://www.sec.gov/Archives/edgar/data/1723128/000089924320007820/0000899243-20-007820-index.htm
2020-03-02Chirag K. PatelPresident, Co-CEO & DirectorBuy34,641.003.87134,060.6740,748.00https://www.sec.gov/Archives/edgar/data/1723128/000089924320007821/0000899243-20-007821-index.htm
2020-03-02Chintu PatelCo-CEO and DirectorBuy34,696.003.87134,273.5240,803.00https://www.sec.gov/Archives/edgar/data/1723128/000089924320007819/0000899243-20-007819-index.htm
2019-05-07PAUL BISAROExecutive ChairmanBuy24,983.0041,983.00https://www.sec.gov/Archives/edgar/data/1723128/000172312819000089/0001723128-19-000089-index.htm
2019-08-28Ted C NarkDirectorBuy50,000.002.39119,500.0056,107.00https://www.sec.gov/Archives/edgar/data/1723128/000172312819000120/0001723128-19-000120-index.htm
2019-05-08Chintu PatelDirectorBuy6,107.006,107.00https://www.sec.gov/Archives/edgar/data/1723128/000172312819000072/0001723128-19-000072-index.htm
2019-05-08Chirag K. PatelDirectorBuy6,107.006,107.00https://www.sec.gov/Archives/edgar/data/1723128/000172312819000065/0001723128-19-000065-index.htm
2019-05-08Dharmendra RamaDirectorBuy6,107.006,107.00https://www.sec.gov/Archives/edgar/data/1723128/000172312819000071/0001723128-19-000071-index.htm
2019-05-08Emily Peterson AlvaDirectorBuy6,107.006,107.00https://www.sec.gov/Archives/edgar/data/1723128/000172312819000064/0001723128-19-000064-index.htm
2019-05-08Gautam PatelDirectorBuy6,107.006,107.00https://www.sec.gov/Archives/edgar/data/1723128/000172312819000073/0001723128-19-000073-index.htm
2019-05-08Jean Selden GreeneDirectorBuy6,107.006,107.00https://www.sec.gov/Archives/edgar/data/1723128/000172312819000066/0001723128-19-000066-index.htm
2019-05-08Ted C NarkDirectorBuy6,107.006,107.00https://www.sec.gov/Archives/edgar/data/1723128/000172312819000070/0001723128-19-000070-index.htm
2020-05-07Ted C NarkDirectorBuy6,459.0062,566.00https://www.sec.gov/Archives/edgar/data/1723128/000089924320012261/0000899243-20-012261-index.htm
2019-03-06PETER R TERRERIDirectorBuy45,000.006.55294,750.0070,192.00https://www.sec.gov/Archives/edgar/data/1723128/000172312819000038/0001723128-19-000038-index.htm
2019-05-15Pradeep BhadauriaSVP, Chief Scientific OfficerBuy7,000.008.4859,360.007,500.00https://www.sec.gov/Archives/edgar/data/1723128/000172312819000097/0001723128-19-000097-index.htm
2019-05-08PETER R TERRERIDirectorBuy6,107.0076,299.00https://www.sec.gov/Archives/edgar/data/1723128/000172312819000067/0001723128-19-000067-index.htm
2020-05-04PETER R TERRERIDirectorBuy6,459.0082,758.00https://www.sec.gov/Archives/edgar/data/1723128/000089924320012068/0000899243-20-012068-index.htm
2019-01-15ROBERT L BURRDirectorBuy30,000.006.55196,500.0090,475.00https://www.sec.gov/Archives/edgar/data/1723128/000172312819000013/0001723128-19-000013-index.htm
2019-08-07ANDREW S BOYERExec VP, Comm OptnsBuy66,666.002.89192,664.7495,968.00https://www.sec.gov/Archives/edgar/data/1723128/000172312819000116/0001723128-19-000116-index.htm
2019-05-08ROBERT L BURRDirectorBuy6,107.0096,582.00https://www.sec.gov/Archives/edgar/data/1723128/000172312819000069/0001723128-19-000069-index.htm